Addiction treatment in New Hampshire

In New Hampshire, the landscape of addiction treatment is shaped by 158 licensed facilities operating within a state-specific regulatory and demographic context located in New England. Evaluating options requires distinguishing three considerations that are frequently conflated: state licensure, voluntary accreditation (CARF, Joint Commission), and clinical-framework alignment with current ASAM Criteria.

The Medicaid question

New Hampshire expanded Medicaid in 2014 under the Affordable Care Act. The operational consequence: facilities serving predominantly Medicaid populations in New Hampshire tend to cluster around specific managed-care contracts, which shapes network adequacy in ways that are auditable under the 2024 parity rule but not always transparent to patients.

The overdose-mortality context

Overdose rate, New Hampshire: 32.0 per 100,000 (CDC 2023). Methodologically this figure captures confirmed fatal overdoses from all categories; the state-specific distribution is dominated by fentanyl and opioids-related mortality, with fentanyl as the primary synthesization risk in opioid-related deaths. The specific context: fentanyl-driven overdose mortality among the highest per capita in New England.

How access actually works in New Hampshire

The 158 licensed facilities in New Hampshire include a mix of hospital-system, private-equity-owned, nonprofit, and state-funded programs. Outcome research consistently finds more variation within categories than across them, which means the clinical-framework question (ASAM-aligned? MAT-offered? evidence-based programming?) is a more productive filter than the ownership-structure question. The specific context: fentanyl-driven overdose mortality among the highest per capita in New England.

What to do next

Optimal patient pathway in New Hampshire: clinical assessment first (addiction-medicine physician, licensed counselor), benefits verification second (in writing, specific to requested level of care), facility selection third (ASAM-aligned, MAT-inclusive, contractually confirmed in-network). Reversing this order — selecting a facility before clinical assessment — produces most of the misaligned-level-of-care outcomes that show up in retrospective treatment research.